Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) currently has a daily average trading volume of 1.38M but it saw 2835089 shares traded in last market. With a market cap of 193.37M USD, the company’s current market price of $26.40 came falling about -6.81 while comparing to the previous closing price of $28.33. In past 52 weeks, the stock remained buoying in the range of price level as high as $624.00 and as low as $6.76.
ROTH Capital upgraded its recommendation for the stock as a “Buy” from “Neutral” on April 18, 2019 while assigning a price target of $4. ROTH Capital issued its recommendations for the stock as it upgraded the price target for the stock is $6.
Over the week, TNXP’s stock price is moving 14.29% up while it is 55.11% when we observe its performance for the past one month. Year-to-date it is -19.95% down and over the past year, the stock is showing a downside performance of -95.66%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0. In next quarter, company is expected to be making quarterly sales of $2.7M as analysts are expecting the sales for current fiscal year at $10.6M and seeing the company making $98.7M in sales next year. Moreover, analysts are in estimates of $2.6M for current-quarter revenue.
Currently, Tonix Pharmaceuticals Holding Corp’s total number of outstanding shares is 7.32M with 0.05% of that held by the insiders while 7.03% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -73.00% and return on equity (ROE) at -91.44%. Stock’s beta reads 1.82. Stock has a price to book (P/B) ratio of 1.01 while price to sale or P/S ratio amounts to 19.26. Its return on asset (ROA) is -80.39% on average.
